Valuation: Bonesupport Holding AB

Market Cap 20.54B 2.1B 1.87B 1.71B 1.56B 2.94B 198B 3.01B 8.21B 105B 7.87B 7.71B 331B P/E 2026 *
63.3x
P/E 2027 * 40x
Enterprise Value 20B 2.04B 1.82B 1.66B 1.52B 2.86B 193B 2.94B 8B 102B 7.67B 7.5B 323B EV / Sales 2026 *
13.2x
EV / Sales 2027 * 9.76x
Free-Float
89.54%
Yield 2026 *
0.47%
Yield 2027 * 0.72%
1 day+3.24%
1 week+2.00%
Current month+0.68%
1 month+41.89%
3 months+47.12%
6 months+46.59%
Current year+74.04%
1 week 305.6
Extreme 305.6
330.2
1 month 218.6
Extreme 218.6
340.2
Current year 165
Extreme 165
340.2
1 year 165
Extreme 165
340.2
3 years 145.9
Extreme 145.9
405.8
5 years 34.2
Extreme 34.2
405.8
10 years 9.04
Extreme 9.04
405.8
Manager TitleAgeSince
Chief Executive Officer 49 01/09/2025
Director of Finance/CFO 63 01/11/2018
Chief Operating Officer 51 01/12/2021
Director TitleAgeSince
Director/Board Member 68 01/01/2010
Chairman 70 15/12/2016
Chairman 71 14/05/2019
Date Insider Type Main position Quantity % Market Cap. Importance
28/08/26 Buy

Public Communications Manager

170 0.0003%
26/08/26 Buy

Director

30 0.0000%
20/07/26 Buy

Chief Executive Officer

1,950 0.0030%
Change 5-day change 1-year change 3-year change Capi.($)
+3.87%+2.00%+64.50%+119.16% 2.1B
-2.76%+1.14%+50.08%+133.44% 1,263B
-0.70%-0.22%+47.63%+81.01% 665B
-0.75%+0.72%+35.12%+107.43% 521B
-1.06%-2.49%+47.76%+65.17% 387B
-1.04%+2.02%+76.90%+43.08% 371B
-0.10%+1.38%+32.03%+59.21% 310B
+0.13%+7.59%+12.79%+36.65% 293B
-2.25%+1.83%+46.68%+71.96% 259B
-2.50%+2.96%+39.10%+110.14% 216B
Average -0.65%+4.92%+45.26%+82.73% 428.75B
Weighted average by Cap. -1.36%+5.95%+45.38%+91.29%

Financials

2026 *2027 *
Net sales 1.52B 155M 138M 127M 115M 217M 14.67B 223M 608M 7.77B 583M 570M 24.52B 2.02B 206M 184M 168M 153M 288M 19.46B 296M 806M 10.31B 773M 756M 32.53B
Net income 328M 33.52M 29.87M 27.32M 24.88M 46.91M 3.17B 48.17M 131M 1.68B 126M 123M 5.29B 520M 53.15M 47.37M 43.32M 39.46M 74.37M 5.02B 76.38M 208M 2.66B 200M 195M 8.39B
Net Debt -541M -55.29M -49.27M -45.07M -41.04M -77.36M -5.23B -79.45M -216M -2.77B -208M -203M -8.73B -867M -88.58M -78.94M -72.2M -65.76M -124M -8.37B -127M -347M -4.43B -332M -325M -13.99B
Projected Income Statement - Annual - Bonesupport Holding AB
Logo Bonesupport Holding AB
Bonesupport Holding AB is a Sweden-based orthobiologics company. It develops and commercialize injectable bioceramic bone graft substitutes which remodel to host bone and have the capability to elute drugs directly into the bone void. The marketed synthetic bone graft substitutes are CERAMENT BVF, CERAMENT G and CERAMENT V, which are based on the CERAMENT technology platform. The products are commercially available in Europe and the United States, as well as in India, Malaysia, Oman and Singapore. The products are developed to treat patients with fractures and bone voids caused by trauma and related surgery, as well as caused by infection or diseases, such as chronic osteomyelitis, revision arthroplasty and infected diabetic foot.
Employees
174
Date Price Change Volume
05/11/26 SEK 327.20 +3.87% 416,156
04/11/26 SEK 315.00 +1.22% 270,370
03/11/26 SEK 311.20 0.00% 282,667
02/11/26 SEK 311.20 -4.25% 314,836
30/10/26 SEK 325.00 +1.31% 247,354
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Bonesupport Holding AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
315.00SEK
Average target price
374.67SEK
Spread / Average Target
+18.94%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Bonesupport Holding AB
  1. Stock Market
  2. Stocks
  3. BONEX Stock